69184-33-4

Basic information

• Product Name: (3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol
• CAS NO: 69184-33-4
• Molecular Formula: C₁₀H₁₉NO₂
• Molecular Weight: 185.2634
• Mol File: 69184-33-4.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 301.8°C at 760 mmHg
• Flash Point: 136.3°C
• Density: 1.09g/cm³
• Vapor Pressure: 0.0001mmHg at 25°C
• Refractive Index: 1.518
• CAS DataBase Reference: (3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol(69184-33-4)
• EPA Substance Registry System: (3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol(69184-33-4)

Safety Data

• Hazardous Substances Data: 69184-33-4(Hazardous Substances Data)

Usage

Description

(3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol, also known as ADMET-PI-1, is a spiro compound with a unique structural configuration. It contains a spiro ring system with both oxygen and nitrogen heteroatoms, as well as a methyl and a methanol group. (3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol has potential applications in the field of medicinal chemistry, particularly in the development of new pharmaceuticals and biologically active molecules. Its spiro ring structure and functional groups make it an interesting target for chemical synthesis and biological evaluation, as it may exhibit diverse biological activities and pharmacological properties.

Uses

Used in Medicinal Chemistry:
(3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol is used as a building block for the development of new pharmaceuticals and biologically active molecules. Its unique spiro ring system and functional groups make it a promising candidate for the synthesis of novel compounds with potential therapeutic applications.
Used in Chemical Synthesis:
(3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol is used as a key intermediate in the synthesis of complex organic molecules. Its spiro ring structure and heteroatoms provide opportunities for further functionalization and the creation of new chemical entities with potential applications in various fields.
Used in Biological Evaluation:
(3-methyl-1-oxa-4-azaspiro[4.5]dec-3-yl)methanol is used as a subject for biological evaluation to explore its potential biological activities and pharmacological properties. Further research and investigations are needed to determine its full potential in various scientific and medical fields.

Upstream product

• 108-94-1 cyclohexanone 
• 115-69-5 2-Amino-2-methylpropane-1,3-diol 

Relevant articles and documents

SYNTHESIS OF SPIROCYCLIC OXAZOLIDINES AND THEIR EFFECTS ON PHYSICAL WORK CAPACITY

-

Phenanthro[2,3-6]thiophene derivatives, pharmaceutical compositions and use

The present invention relates to anti tumor compounds of formula (I) or a monomethyl or monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 29 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; wherein Ar is a fused tetracyclic aromatic ring system comprised of 5-membered and 6-membered rings and contains at least one heteroatom and 3 aromatic rings and a total of no more than 18 ring atoms, or a substituted derivative thereof; the heteroatom is preferably oxygen, sulfur or nitrogen; when it is nitrogen this is substituted by hydrogen, methyl or ethyl; R1 contains not more than eight carbon atoms and is a group STR1 wherein m is 0 or 1; R5 is hydrogen; R6 and R7 are the same or different and each is hydrogen or C1-5 alkyl optionally substituted by hydroxy; R8 and R9 are the same or different and each is hydrogen or C1-3 alkyl; STR2 is a five or six-membered saturated carbocyclic ring; R10 is hydrogen, methyl or hydroxymethyl; R11, R12 and R13 are the same or different and each is hydrogen or methyl; R14 is hydrogen, methyl, hydroxy, or hydroxymethyl.

Anthracene derivatives

The present invention relates to compounds of formula (I) or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; wherein Ar is an anthracene or substituted anthracene ring system; R1 contains not more than eight carbon carbon atoms and is a group STR1 wherein m is 0 or 1; R5 is hydrogen; R6 and R7 are the same or different and each is hydrogen or C1-3 alkyl optionally substituted by hydroxy; R8 and R9 are the same or different and each is hydrogen or C1-3 alkyl; --C--C-- is a five- or six-membered saturated carbocyclic ring; R10 is hydrogen, methyl or hydroxymethyl; R11, R12 and R13 are the same or different and each is hydrogen or methyl; R14 is hydrogen, methyl, hydroxy, or hydroxymethyl.